Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Psychiatry & Neuroscience : JPN
|
January 14, 2004
The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression
Marieke C Wichers, Michael Maes
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 8, 2005
Cytokines and major depression
Olga J G Schiepers, Marieke C Wichers, Michael Maes
Biological Psychiatry
|
February 21, 2006
Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment
Marieke C Wichers, Gunter Kenis, Carsten Leue, et al.
Journal of Psychosomatic Research
|
February 3, 2007
Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol
Marieke C Wichers, Gunter Kenis, Ger H Koek, et al.
BMC Medical Research Methodology
|
November 18, 2018
A qualitative approach to guide choices for designing a diary study
Karin A M Janssens, Elisabeth H Bos, Judith G M Rosmalen, et al.
World Journal of Gastroenterology
|
October 30, 2007
Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks
Geert Robaeys, Jozef De Bie, Marieke C Wichers, et al.
Acta Psychiatrica Scandinavica
|
May 15, 2007
Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study
Marieke C Wichers, Inez Myin-Germeys, Nele Jacobs, et al.
Psychosomatic Medicine
|
April 2, 2008
Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study
Marieke C Wichers, Inez Myin-Germeys, Nele Jacobs, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Psychiatry & Neuroscience : JPN
|
January 14, 2004
The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression
Marieke C Wichers, Michael Maes
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 8, 2005
Cytokines and major depression
Olga J G Schiepers, Marieke C Wichers, Michael Maes
Biological Psychiatry
|
February 21, 2006
Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment
Marieke C Wichers, Gunter Kenis, Carsten Leue, et al.
Journal of Psychosomatic Research
|
February 3, 2007
Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol
Marieke C Wichers, Gunter Kenis, Ger H Koek, et al.
BMC Medical Research Methodology
|
November 18, 2018
A qualitative approach to guide choices for designing a diary study
Karin A M Janssens, Elisabeth H Bos, Judith G M Rosmalen, et al.
World Journal of Gastroenterology
|
October 30, 2007
Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks
Geert Robaeys, Jozef De Bie, Marieke C Wichers, et al.
Acta Psychiatrica Scandinavica
|
May 15, 2007
Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study
Marieke C Wichers, Inez Myin-Germeys, Nele Jacobs, et al.
Psychosomatic Medicine
|
April 2, 2008
Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study
Marieke C Wichers, Inez Myin-Germeys, Nele Jacobs, et al.
Page
of 1